isoquinoline has been researched along with Breast Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faundes, J; Ibacache, JA; Mejías, S; Montoya, M; Valderrama, JA | 1 |
Bielawska, A; Bielawski, K; Czarnomysy, R; Gornowicz, A; Kałuża, Z; Lepiarczyk, M | 1 |
Al-Dosari, MS; Al-Mishari, AA; Almoqbil, AN; Alsaid, MS; Ghorab, MM; Ragab, FA | 1 |
3 other study(ies) available for isoquinoline and Breast Neoplasms
Article | Year |
---|---|
Preparation of Novel Homodimers Derived from Cytotoxic Isoquinolinequinones. A Twin Drug Approach.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Benzoquinones; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Isoquinolines; Melanoma, Experimental; Mice | 2018 |
Cytotoxic activity of octahydropyrazin[2,1-a:5,4-a']diisoquinoline derivatives in human breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Cytotoxins; Dose-Response Relationship, Drug; Female; Humans; Isoquinolines; MCF-7 Cells; Membrane Potential, Mitochondrial; Pyrazines | 2015 |
Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Inhibitory Concentration 50; Isoquinolines; MCF-7 Cells; Models, Molecular; Molecular Structure; Pyridines; Quinolines; Structure-Activity Relationship; Thiazoles; Thiazolidines; Thiophenes | 2016 |